CYP17A1 Inhibitor II, TAK-700
CAS: 566939-85-3
Ref. 3D-RXA93985
5mg | 334.00 € | ||
10mg | 502.00 € | ||
25mg | 799.00 € | ||
50mg | 1,203.00 € | ||
100mg | 1,924.00 € |
Product Information
- 6-[(7S)-6,7-Dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide
- 6-[(7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide
- TAK 700
- 2-Naphthalenecarboxamide, 6-[(7S)-6,7-dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-
- Orteronel
TAK-700 is a CYP17A1 inhibitor that prevents the production of androgens by inhibiting the activity of cytochrome P450, which is known to be involved in the conversion of androstenedione to testosterone. TAK-700 has been shown to inhibit the growth of prostate cancer cells in vitro. It also has anti-inflammatory properties and can be used for the treatment of infectious diseases.
Chemical properties
Technical inquiry about: 3D-RXA93985 CYP17A1 Inhibitor II, TAK-700
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.